C. Sridar

发表

Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.

T. Goosen, J. Williams, P. Hollenberg, 2004, Drug metabolism and disposition: the biological fate of chemicals.

The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6

M. Sikora, J. Rae, T. Feuerstein, 2008, Journal of Pharmacology and Experimental Therapeutics.

The Inactivation of Human CYP2E1 by Phenethyl Isothiocyanate, a Naturally Occurring Chemopreventive Agent, and Its Oxidative Bioactivation

P. Hollenberg, Y. Yoshigae, U. Kent, 2013, Drug Metabolism and Disposition.

Bioactivation of the Cancer Chemopreventive Agent Tamoxifen to Quinone Methides by Cytochrome P4502B6 and Identification of the Modified Residue on the Apoprotein

P. Hollenberg, Jaime D’Agostino, C. Sridar, 2012, Drug Metabolism and Disposition.

Differential Inhibition of Cytochromes P450 3A4 and 3A5 by the Newly Synthesized Coumarin Derivatives 7-Coumarin Propargyl Ether and 7-(4-Trifluoromethyl)coumarin Propargyl Ether

M. Foroozesh, P. Hollenberg, Alecia M. Mccall, 2008, Drug Metabolism and Disposition.

Process Development of GaAs Based RF MEMS Switch

S. Koul, R. Muralidharan, P. Suryanarayana, 2009 .

Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex

D. Ballou, P. Hollenberg, Haoming Zhang, 2011, Journal of Pharmacology and Experimental Therapeutics.

Modification of Serine 360 by a Reactive Intermediate of 17- α Ethynylestradiol Leads to Mechanism-based Inactivation of Cytochrome P450s 2B1 and 2B6

P. Hollenberg, Greg Spahlinger, U. Kent, 2009 .

Synthesis of Substituted Phenyl Diaziridines and Characterization as Mechanism-Based Inactivators of Human Cytochrome P450 2B6

J. Rimoldi, P. Hollenberg, Holly N. Brevig, 2006, Drug Metabolism and Disposition.

Roles of the threonine 407, aspartic acid 417, and threonine 419 residues in P450 2B1 in metabolism.

P. Hollenberg, C. Sridar, Erin Harleton, 2005, Biochemical and biophysical research communications.

Inhibition of Bupropion Metabolism by Selegiline: Mechanism-Based Inactivation of Human CYP2B6 and Characterization of Glutathione and Peptide Adducts

P. Hollenberg, C. Sridar, C. Kenaan, 2012, Drug Metabolism and Disposition.

THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION

Namandjé N. Bumpus, P. Hollenberg, U. Kent, 2005, Drug Metabolism and Disposition.

The Naturally Occurring P450 2B6 K262R Mutant of P450 2B6 Exhibits Alterations in Substrate Metabolism and Inactivation

Namandjé N. Bumpus, P. Hollenberg, U. Kent, 2005 .

The inactivation of human cytochrom,e P4502E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation

P. Hollenberg, Y. Yoshigae, U. Kent, 2013 .

Structure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl Diaziridines

L. Waskell, J. Rimoldi, P. Hollenberg, 2006, Drug Metabolism and Disposition.

Identification of Amino Acid Residues Involved in the Inactivation of Cytochrome P450 2B1 by Two Acetylenic Compounds: The Role of Three Residues in Nonsubstrate Recognition Sites

P. Hollenberg, L. V. von Weymarn, C. Sridar, 2004, Journal of Pharmacology and Experimental Therapeutics.

Modification of serine 360 by a reactive intermediate of 17-alpha-ethynylestradiol results in mechanism-based inactivation of cytochrome P450s 2B1 and 2B6.

P. Hollenberg, Greg Spahlinger, U. Kent, 2008, Chemical research in toxicology.

Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6.

E. Gillam, P. Hollenberg, L. Notley, 2002, The Journal of pharmacology and experimental therapeutics.

Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP2B6 and CYP2D6

Natasha T. Snider, P. Hollenberg, Paul F. Hollenberg, 2011, Drug Metabolism and Disposition.

Microsoft Word-25727521-file00.docx

Natasha T. Snider, P. Hollenberg, C. Sridar, 2011 .

Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP 2 B 6 and CYP 2 D 6

Natasha T. Snider, P. Hollenberg, C. Sridar, 2011 .

Quantitation of UGT1A1 in human liver microsomes using stable isotope-labelled peptides and mass spectrometry based proteomic approaches

Imad Hanna, P. Hollenberg, Paul F Hollenberg, 2013, Xenobiotica; the fate of foreign compounds in biological systems.

Investigating the effects and mechanisms of interaction between cytochrome P450 2B4, cytochrome P450 2E1 and cytochrome P450 reductase

D. Calinski, D. Ballou, M. Saper, 2012 .

THE NATURALLY OCCURRING CYTOCHROME P 450 ( P 450 ) 2 B 6 K 262 R MUTANT OF P 450 2 B 6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION

Namandjé N. Bumpus, P. Hollenberg, U. Kent, 2005 .